Literature DB >> 6483135

Temporary neurological deterioration after extracranial-intracranial bypass.

R C Heros, R M Scott, J P Kistler, R H Ackerman, E S Conner.   

Abstract

Five patients who experienced temporary neurological deterioration after extracranial to intracranial bypass procedures are reported in detail. These patients suffered transient ischemic attacks or more prolonged deficits usually of a different nature than the preoperative symptoms. All patients had a good outcome and the spells ceased; the neurological deficits improved within a maximum of 2 weeks. Obvious causes of deterioration such as intra- or extracerebral hematomas, occlusion of a previously stenotic vessel, or graft occlusion were ruled out by computed tomography and angiography in each case. Intraoperative causes of neurological deterioration such as anesthetic effect, hypotension, and temporary occlusion of the cortical vessel or sacrifice of its small branches were not likely to be the cause of the deficits because in each case, the patient awoke satisfactorily and deterioration occurred hours to days later. In each case, postoperative angiography showed good perfusion of at least one major division of the middle cerebral territory. Anticoagulation with heparin in three patients did not change the clinical course. In one patient who was not anticoagulated, embolism could have been responsible for a single prolonged ischemic event, but in the other patients thromboembolism does not seem likely to have been responsible for the deficits. The cause of the deterioration in these patients remains unexplained. We speculate that hyperperfusion of chronically ischemic brain tissue and shifts in the watershed region resulting from the new flow pattern after bypass grafting are two mechanisms that may have been of importance in the etiology of these deficits.

Entities:  

Mesh:

Year:  1984        PMID: 6483135     DOI: 10.1227/00006123-198408000-00006

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  6 in total

1.  Efficacy of superficial temporal artery-middle cerebral artery anastomosis with routine postoperative cerebral blood flow measurement during the acute stage in childhood moyamoya disease.

Authors:  Miki Fujimura; Tomohiro Kaneta; Teiji Tominaga
Journal:  Childs Nerv Syst       Date:  2007-12-08       Impact factor: 1.475

2.  Cortical blood flow and cognition after extracranial-intracranial bypass in a patient with severe carotid occlusive lesions. A three-year follow-up study.

Authors:  Y Tsuda; K Yamada; T Hayakawa; Y Ayada; S Kawasaki; H Matsuo
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

3.  Quantitative cerebral perfusion assessment using microscope-integrated analysis of intraoperative indocyanine green fluorescence angiography versus positron emission tomography in superficial temporal artery to middle cerebral artery anastomosis.

Authors:  Shinya Kobayashi; Tatsuya Ishikawa; Jun Tanabe; Junta Moroi; Akifumi Suzuki
Journal:  Surg Neurol Int       Date:  2014-09-15

4.  Intracerebral Hemorrhage Caused by Cerebral Hyperperfusion after Superficial Temporal Artery to Middle Cerebral Artery Bypass for Atherosclerotic Occlusive Cerebrovascular Disease.

Authors:  Fumihiro Matano; Yasuo Murai; Takayuki Mizunari; Koji Adachi; Shiro Kobayashi; Akio Morita
Journal:  NMC Case Rep J       Date:  2016-12-05

5.  Cerebral Hyperperfusion and Concomitant Reversible Lesion at the Splenium after Direct Revascularization Surgery for Adult Moyamoya Disease: Possible Involvement of MERS and Watershed Shift Phenomenon.

Authors:  Ryosuke Tashiro; Miki Fujimura; Taketo Nishizawa; Atsushi Saito; Teiji Tominaga
Journal:  NMC Case Rep J       Date:  2021-08-06

6.  Hyperperfusion Syndrome Detected by 15O-Gas Positron Emission Tomography after Clipping of a Large Unruptured Internal Carotid Artery Aneurysm: A Case Report.

Authors:  Takao Koiso; Daisuke Maruyama; Eika Hamano; Hisae Mori; Tetsu Satow; Hiroharu Kataoka; Jyoji Nakagawara; Jun C Takahashi
Journal:  NMC Case Rep J       Date:  2021-06-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.